# FY19 TRIAL EXECUTION OPTION ITEM #2 - KENNY-PHASE I SINGLE ASCENDING DOSE STUDY-BPN-19302 (AZD4041) PROTOCOL DEVELOPMENT AND FINALIZATION AND DATABASE BUILD AND BIOANALYTICAL METHODS DEVELOPMENT FOR C

> **NIH NIH N01** · PPD DEVELOPMENT, LP · 2020 · $476,848

## Abstract

PHASE I CLINICAL TRIALS FOR DEVELOPMENT OF NEUROTHERAPEUTICS

## Key facts

- **NIH application ID:** 10263137
- **Project number:** 271201600005I-P00004-759501900088-1
- **Recipient organization:** PPD DEVELOPMENT, LP
- **Principal Investigator:** MATTHEW KIRKBY
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $476,848
- **Award type:** —
- **Project period:** 2019-07-01 → 2021-09-11

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10263137

## Citation

> US National Institutes of Health, RePORTER application 10263137, FY19 TRIAL EXECUTION OPTION ITEM #2 - KENNY-PHASE I SINGLE ASCENDING DOSE STUDY-BPN-19302 (AZD4041) PROTOCOL DEVELOPMENT AND FINALIZATION AND DATABASE BUILD AND BIOANALYTICAL METHODS DEVELOPMENT FOR C (271201600005I-P00004-759501900088-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10263137. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*